| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rg7388 | erbb4 tyrosine kinase receptor | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Hematologic Neoplasms[MeSHID:D019337] Malignant Neoplasms[MeSHID:D009369] Polycythemia Vera[MeSHID:D011087] |
NA | phase 3 | unknown |
| rg7388 | ubiquitin-protein ligase e3 mdm2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Hematologic Neoplasms[MeSHID:D019337] Malignant Neoplasms[MeSHID:D009369] Polycythemia Vera[MeSHID:D011087] |
3.98 | phase 3 | unknown |
| click here to return to the previous page | ||||||||